FORMULATIONS OF HISTONE DEACETYLASE INHIBITOR AND USES THEROF

摘要

Dosing regimens, methods of treatment, controlled release formulations, and combination therapies that include an HDAC inhibitor, or a pharmaceutically acceptable salt thereof, are described.

主权项

1. A method of treating cancer in an individual in need thereof comprising orally administering a first dose of an HDAC inhibitor at a first time and orally administering a second dose of the HDAC inhibitor at a second time, wherein an effective plasma concentration of the HDAC inhibitor is maintained for at least 6 consecutive hours.